Company news

Ikonisys Sa (EURONEXT:ALIKO) news

Ikonisys Sa news releases on 6ix. Latest, Sep 21, 2026: ALIKO Scientific Announces Settlement of a Dispute Involving Its US Subsidiary, Which Will Receive USD…

View Ikonisys Sa →

Press releases & updates

ALIKO Scientific Announces Settlement of a Dispute Involving Its US Subsidiary, Which Will Receive USD 2 Million

September 21, 2026

Aliko Scientific Launches Probantes in Brazil and Establishes a New Molecular Diagnostic Development and Commercial Platform for South America

September 15, 2026

Aliko Scientific Successfully Launches U.S. Business Development Collaboration With Partner International at ADLM 2026, the World’s Largest Molecular Diagnostics Exhibition

September 7, 2026

Aliko Scientific Provides a Financial Update Following the Publication of its FY 2025 Results and Reaffirms Its Business Momentum

August 24, 2026

Aliko Scientific Signs New Distribution Agreements in Romania and Saudi Arabia, Strengthening Its International Commercial Network

August 5, 2026

Ikonisys SA Reports its Full-Year Financial Results for 2025 and Provides an Update on Its Latest Developments

July 30, 2026

Aliko Scientific: Hospitex International Signs First Agreement With the Uzbek Oncology Institute for the Feasibility Study of a National Urine24 Screening Project

July 23, 2026

Aliko Scientific S A : Update on the suspension of trading of ALIKO shares on Euronext Growth Paris and postponement of the publication of the 2025 annual financial report

June 19, 2026

Aliko Scientific Signs Memorandum of Understanding with BioBrasil for Brazilian FISH Probe Manufacturing Joint Venture

May 25, 2026

Aliko Scientific Announces Award of Major Five-Year Public Tender at Federico II University Hospital

May 19, 2026

Aliko Scientific S A : Announces Award of Major Five-Year Public Tender at Federico II University Hospital

May 19, 2026

Aliko Scientific Signs Strategic Memorandum of Understanding with Cellay Inc. and Secures First Commercial Customer in Arizona

May 11, 2026

Aliko Scientific S A : Ikonisys announces the postponement of the publication of its 2025 annual financial report

April 23, 2026

Ikonisys: Hospitex International Signs Strategic Distribution Agreement With Naturneed for Urine24, Strengthening Its Commercial Footprint in the Italian Urology Diagnostics Market

March 10, 2026

Aliko Scientific: Outstanding Success at WHX Labs Dubai With 172 Commercial Leads and Strong Global Interest in the New Integrated Oncology Diagnostics Platform

February 24, 2026

Aliko Scientific: Francesco Trisolini Appointed as New Group CEO to Pursue the Implementation of the Approved Industrial Plan

February 18, 2026

Aliko Scientific: Shareholders’ Meeting appoints Francesco Trisolini as Group CEO and for implementation of the approved industrial plan

February 17, 2026

Ikonisys finalized a Capital Increase and Debt Conversion of EUR 2.72 million with strategic investment from Avantgarde Srl and Alberto Previtali

December 19, 2025

Ikonisys: Cytofast Auto: The First Fully Automatic Universal Monolayer Cytology Processor Is Born

December 4, 2025

Ikonisys: Hospitex Initiates International Dialogues for Pilot Projects in Oncology Diagnostics Following ADB Delegation Visit

November 24, 2025

Ikonisys SA: Hospitex Wins Public Tender at Policlinico di Bari for Cytofast Cytology Systems

October 7, 2025

Ikonisys S A : reports its Full-Year Financial Results for 2024 and provides an update on its latest developments

September 25, 2025

Ikonisys S A : publie ses résultats financiers annuels pour 2024 et fait le point sur ses dernières actualités

September 25, 2025

Ikonisys SA: Suspension of Trading of Shares on Euronext Growth Paris Until the Publication of the 2024 Annual Report

July 1, 2025

ALIKO SCIENTIFIC (Ikonisys SA), Through Its Fully Owned Italian Subsidiary Hospitex International, Signs Exclusive Distribution Agreement for Italy with Menarini Diagnostics

June 4, 2025

Ikonisys Announces a Further Postponement of the Publication of Its 2024 Annual Financial Report

May 30, 2025

Ikonisys Finalized a Capital Increase Through the Offsetting of Debt

May 2, 2025

Ikonisys Announces the Postponement of the Publication of Its 2024 Annual Financial Report

April 25, 2025